Your browser doesn't support javascript.
loading
Systems Biology in ELIXIR: modelling in the spotlight.
Martins Dos Santos, Vitor; Anton, Mihail; Szomolay, Barbara; Ostaszewski, Marek; Arts, Ilja; Benfeitas, Rui; Dominguez Del Angel, Victoria; Ferk, Polonca; Fey, Dirk; Goble, Carole; Golebiewski, Martin; Gruden, Kristina; Heil, Katharina F; Hermjakob, Henning; Kahlem, Pascal; Klapa, Maria I; Koehorst, Jasper; Kolodkin, Alexey; Kutmon, Martina; Leskosek, Brane; Moretti, Sébastien; Müller, Wolfgang; Pagni, Marco; Rezen, Tadeja; Rocha, Miguel; Rozman, Damjana; Safránek, David; Sheriff, Rahuman S Malik; Suarez Diez, Maria; Van Steen, Kristel; Westerhoff, Hans V; Wittig, Ulrike; Wolstencroft, Katherine; Zupanic, Anze; Evelo, Chris T; Hancock, John M.
Afiliação
  • Martins Dos Santos V; Laboratory of Bioprocess Engineering, Wageningen University & Research, Wageningen, 6708 PB, The Netherlands.
  • Anton M; Department of Biology and Biological Engineering, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Chalmers University of Technology, Gothenburg, SE-41258, Sweden.
  • Szomolay B; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Ostaszewski M; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, L-4367, Luxembourg.
  • Arts I; Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, 6200 MD, The Netherlands.
  • Benfeitas R; National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
  • Dominguez Del Angel V; Research and Platforms Department, Genopole, Evry-Courcouronnes, 91030, France.
  • Ferk P; Faculty of Medicine, Institute for Biostatistics and Medical Informatics, Centre ELIXIR-SI, University of Ljubljana, Ljubljana, SI-1000, Slovenia.
  • Fey D; Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, 4, Ireland.
  • Goble C; Department of Computer Science, The University of Manchester, Manchester, M13 9PL, UK.
  • Golebiewski M; Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.
  • Gruden K; Department of Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, SI-1000, Slovenia.
  • Heil KF; ELIXIR Hub, Hinxton, Cambridge, CB10 1SD, UK.
  • Hermjakob H; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, CB10 1SD, UK.
  • Kahlem P; Scientific Network Management SL, Barcelona, 08015, Spain.
  • Klapa MI; Metabolic Engineering & Systems Biology Laboratory, Institute of Chemical Engineering Sciences, Foundation for Research & Technology - Hellas (FORTH/ICE-HT), Patras, 26504, Greece.
  • Koehorst J; Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, 6708WE, The Netherlands.
  • Kolodkin A; ISBE.NL, VU University of Amsterdam, Amsterdam, The Netherlands.
  • Kutmon M; Competence Center for Methodology and Statistics; Transversal Translational Medicine, Translational Medicine Operations Hub, Luxembourg Institute of Health, Strassen, L-1445, Luxembourg.
  • Leskosek B; Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, 6200 MD, The Netherlands.
  • Moretti S; Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, 6200 MD, The Netherlands.
  • Müller W; Faculty of Medicine, Institute for Biostatistics and Medical Informatics, Centre ELIXIR-SI, University of Ljubljana, Ljubljana, SI-1000, Slovenia.
  • Pagni M; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Rezen T; Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.
  • Rocha M; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Rozman D; Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1000, Slovenia.
  • Safránek D; Centre of Biological Engineering, University of Minho, Braga, Portugal.
  • Sheriff RSM; Faculty of Medicine, University of Ljubljana, Ljubljana, SI-1000, Slovenia.
  • Suarez Diez M; Faculty of Informatics, Masaryk University, Brno, 602 00, Czech Republic.
  • Van Steen K; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, CB10 1SD, UK.
  • Westerhoff HV; Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, 6708WE, The Netherlands.
  • Wittig U; BIO3 - Systems Genetics, GIGA-R Medical Genomics, University of Liege, Liege, 4000, Belgium.
  • Wolstencroft K; BIO3 - Laboratory for Systems Medicine, Department of Human Genetics, KU Leuven, Leuven, 3000, Belgium.
  • Zupanic A; ISBE.NL, VU University of Amsterdam, Amsterdam, The Netherlands.
  • Evelo CT; Heidelberg Institute for Theoretical Studies - HITS, Heidelberg, 69118, Germany.
  • Hancock JM; Leiden Institute of Advanced Computer Science, Leiden University, Leiden, 2333 CA, The Netherlands.
F1000Res ; 112022.
Article em En | MEDLINE | ID: mdl-36742342
ABSTRACT
In this white paper, we describe the founding of a new ELIXIR Community - the Systems Biology Community - and its proposed future contributions to both ELIXIR and the broader community of systems biologists in Europe and worldwide. The Community believes that the infrastructure aspects of systems biology - databases, (modelling) tools and standards development, as well as training and access to cloud infrastructure - are not only appropriate components of the ELIXIR infrastructure, but will prove key components of ELIXIR's future support of advanced biological applications and personalised medicine. By way of a series of meetings, the Community identified seven key areas for its future activities, reflecting both future needs and previous and current activities within ELIXIR Platforms and Communities. These are overcoming barriers to the wider uptake of systems biology; linking new and existing data to systems biology models; interoperability of systems biology resources; further development and embedding of systems medicine; provisioning of modelling as a service; building and coordinating capacity building and training resources; and supporting industrial embedding of systems biology. A set of objectives for the Community has been identified under four main headline areas Standardisation and Interoperability, Technology, Capacity Building and Training, and Industrial Embedding. These are grouped into short-term (3-year), mid-term (6-year) and long-term (10-year) objectives.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia de Sistemas País/Região como assunto: Europa Idioma: En Revista: F1000Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia de Sistemas País/Região como assunto: Europa Idioma: En Revista: F1000Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda